BRIEF published on 06/05/2024 at 08:05, 5 months 17 days ago Cairn Homes Plc Announces Share Buyback Transaction Ordinary Shares Share Buyback Cairn Homes Plc Stock Repurchase
PRESS RELEASE published on 06/05/2024 at 08:00, 5 months 17 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 100,000 of its own ordinary shares on Euronext Dublin and the London Stock Exchange through Goodbody Stockbrokers UC, as detailed below Share Buyback Cairn Homes Plc Own Shares Transaction Goodbody Stockbrokers UC
BRIEF published on 06/04/2024 at 12:53, 5 months 18 days ago Cairn Homes Plc Announces Total Voting Rights Voting Rights Cairn Homes Regulation Compliance Shares Issued Dublin/London
PRESS RELEASE published on 06/04/2024 at 12:48, 5 months 18 days ago Cairn Homes Plc: Total Voting Rights Cairn Homes Plc confirms total voting rights as of 3 June 2024 were 645,385,802 Ordinary Shares with one vote each. Shareholders must notify any interest changes based on this figure Shareholders Ordinary Shares Cairn Homes Plc Total Voting Rights Transparency Directive
BRIEF published on 06/04/2024 at 08:05, 5 months 18 days ago Cairn Homes Plc Purchases Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Goodbody Stockbrokers
PRESS RELEASE published on 06/04/2024 at 08:00, 5 months 18 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased 97,515 of its ordinary shares on Euronext Dublin and the London Stock Exchange. The repurchased shares will be cancelled as part of the share buyback program London Stock Exchange Share Buyback Cairn Homes Plc Euronext Dublin Cancellation
BRIEF published on 06/03/2024 at 08:05, 5 months 19 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Stock Repurchase
PRESS RELEASE published on 06/03/2024 at 08:00, 5 months 19 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc purchased a total of 99,185 of its ordinary shares on Euronext Dublin and London Stock Exchange. The repurchased shares will be cancelled as part of the share buyback programme London Stock Exchange Share Buyback Programme Cairn Homes Plc Euronext Dublin Cancellation
BRIEF published on 05/31/2024 at 08:05, 5 months 22 days ago Cairn Homes Plc: Transaction in Own Shares London Stock Exchange Share Buyback Euronext Dublin Cairn Homes Stock Repurchase
PRESS RELEASE published on 05/31/2024 at 08:00, 5 months 22 days ago Cairn Homes Plc: Transaction in Own Shares Cairn Homes Plc announces the purchase of 100,000 of its ordinary shares on Euronext Dublin and the London Stock Exchange, part of its share buyback program London Stock Exchange Ordinary Shares Share Buyback Cairn Homes Plc Euronext Dublin
Published on 11/22/2024 at 23:55, 6 hours 50 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 7 hours 15 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 7 hours 40 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 8 hours 15 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 12 hours 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 12 hours 52 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 13 hours 50 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 14 hours 45 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 23 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 11 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 13 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 13 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
